Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EF5 Binding in Gynecologic Cancer
NCT00107445Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Feb 2005
- Primary completion
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ef5 in Cervical Cancer (CC), endometrial cancer (EC), ovarian epithelial cancer, primary peritoneal cancer (PPC), sponsored by National Cancer Institute. Started Feb 2005; status: completed.
02
Drugs
ef5
03
Conditions
Cervical Cancer (CC)endometrial cancer (EC)ovarian epithelial cancerprimary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT00107445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00107445.